UC Receives $1.68 Million to Study Estrogen Danger In Packaging
CINCINNATIUniversity of Cincinnati (UC) researcher Scott Belcher, PhD, has received a five-year, $1.68 million dollar grant from the National Institute of Environmental Health Sciences (NIEHS) to continue his research into the effects of environmental estrogens on the developing brain.
Last year Belcher and his team published two articles in the journal Endocrinology showing that surprisingly low doses of the chemical bisphenol A (BPA), widely used in products such as food can linings, milk containers, water pipes and dental sealants, affects developing brain tissue.
Belcher, an associate professor in the department of pharmacology and cell biophysics, says the funding will support his groups continuing research into the effects of BPA and other plastic compounds on brain development.
Findings from our lab and others across the world already show that the health risk from estrogens in everyday packaging is important and has the potential of being a major human health problem, says Belcher.
Belcher has also been invited to chair a session at a major NIEHS-sponsored workshop that will bring together scientists from different disciplines who have conducted research on BPA.
The workshop, Nov. 28 and 29 in
Were giving regulators an opportunity to learn about the science of BPA so they can appreciate the scientific communitys concern about this important issue, Belcher says.
Also representing UC at the workshop will be two other nationally recognized researchers into the health effects of BPA: Shuk-mei Ho, PhD, professor and chair of the environmental health department, and Karen Knudsen, PhD, assistant professor in cell biology, neurology and anatomy.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.